Deutsche Bank is out with its report on Danaher DHR, commenting on Q410 results.
In a note to clients, Deutsche Bank writes, "Core revenue growth was very strong with revenues exceeding our estimates by 2% at $3.61bn. Core revenues grew 13%, ahead of our 10% forecast driven by T&M (24% vs. 17% DBe), Environmental (9% - in line), Life Sciences (10% vs. 7% DBe), Dental (7.5% vs. 4% DBe) and Industrial Tech (15.5% vs. 14% DBe). Overall Income ex-items came in line at $627m. The underlying tax rate came in a bit lighter at 25% ex-$24m of items but FCF was outstanding at $501m."
Deutsche Bank maintains Buy and a $54 PT on DHR.
Shares of DHR are trading at $46.82, down 1.01% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in